Carillon Tower Advisers’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $186M | Buy |
2,543,104
+1,033,375
| +68% | +$75.6M | 1.13% | 7 |
|
|
2020
Q3 | $117M | Sell |
1,509,729
-900,861
| -37% | -$70M | 1.56% | 2 |
|
|
2020
Q2 | $134M | Buy |
2,410,590
+794,796
| +49% | +$44.2M | 1.03% | 8 |
|
|
2020
Q1 | $48.6M | Buy |
1,615,794
+414,850
| +35% | +$12.5M | 0.48% | 55 |
|
|
2019
Q4 | $43.5M | Sell |
1,200,944
-604,942
| -33% | -$21.9M | 0.29% | 121 |
|
|
2019
Q3 | $49.2M | Hold |
1,805,886
| – | – | 0.34% | 98 |
|
|
2019
Q2 | $43.4M | Hold |
1,805,886
| – | – | 0.3% | 117 |
|
|
2019
Q1 | $47.7M | Hold |
1,805,886
| – | – | 0.34% | 104 |
|
|
2018
Q4 | $35.3M | Hold |
1,805,886
| – | – | 0.3% | 124 |
|
|
2018
Q3 | $35.4M | Hold |
1,805,886
| – | – | 0.25% | 160 |
|
|
2018
Q2 | $29.9M | Buy |
+1,805,886
| New | +$29.9M | 0.24% | 153 |
|